The purpose of this document is to provide an overview of the traction and progress of Levels over the course of a year – from October 2020 through September 2021. This document is not a deep dive on tactics; rather, it's a retrospective on execution and growth since raising a $12.5M Seed round in October 2020.
https://www.loom.com/share/602279557d49434b9c282831d51c6b09
<aside> 📈 Find a summary for each functional area below, and go into each area's year in review for additional detail.
</aside>
Iterated on our core product and released dozens of new features to respond to member feedback and explore product fit with various member segments.
<aside> 🗒️ 2021 Highlights
Product & Design – 2021 Year in Review
Built operations framework and processes to prepare for 10x scale with a product launch.
Forged relationships with the two key manufacturers in the CGM industry.
<aside> 🗒️ 2021 Highlights
Operations – 2021 Year in Review
Our positioning at the intersection of scalable software, data-science, education/thought leadership, and brand recognition, makes Levels uniquely capable of influencing the direction of metabolic research and incorporating those findings back into our consumer product experience.
In 2021 we built partnerships and launched studies with leading metabolic health researchers to explore mechanisms of metabolic dysfunction and validate the impact of Levels on general population glucose patterns.
<aside> 🗒️ 2021 Highlights
Research – 2021 Year in Review
Our engineering focus in 2021 has been iterating on product development, building integrations to ingest health-related data, scaling our data processing capabilities, and maintaining reliable systems.
<aside> 🗒️ 2021 Highlights
Engineering – 2021 Year in Review
Built an editorial site to produce high quality metabolic health content – a cornerstone of our education and growth strategy.
<aside> 🗒️ 2021 Highlights